Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Several experiences of multidisciplinary care pathways associating oncologists, pharmacists and nurses have been reported for cancer patients, with positive results on medication management safety, reduction of Drug-Related Problems (DRPs), and re-hospitalizations.
This study aims to evaluate the impact of a multidisciplinary city-hospital follow-up program on medication management safety in haematological oncology patients receiving intravenous chemotherapy in onco-haematology. Additional aspects will be evaluated, such as the impact of the follow-up on the city-hospital link, satisfaction of patients and professionals involved in the follow-up and the use of telecare
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| R-CHOP or G-CHOP chemotherapy | Patients with hematological malignancies receiving R-CHOP or G-CHOP chemotherapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessment of patient satisfaction regarding tele-consultation | Other | Questionnaire completed following the teleconsultation, if applicable. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the clinical impact of pharmacist interventions at first cycle of chemotherapy, according to the CLEO© scale. | Each pharmacist intervention performed during patient follow-up will be rated according to its expected level of clinic impact (major, moderate, minor, null) | 6 months after inclusion |
Not provided
Not provided
Inclusion Criteria:
Adult patients aged 18 years or older With hematological malignancy at any stage Initiating R-CHOP or G-CHOP chemotherapy Who do not object to participation in the study and use of collected data
Exclusion Criteria:
Patients already enrolled in a clinical trial evaluating any drug product
Patients living in an institution
Patients protected by law
Not provided
Not provided
Not provided
150 patients treated in the hematology department of a university hospital
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Lyon Sud - Hospices Civils de lyon | Pierre-Bénite | 69495 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Literacy questionnaire | Other | Questionnaire completed during hospitalization for the first chemotherapy cycle |
|
| Collection of socio-demographic characteristics | Other | Questionnaire completed during patient hospitalization for the first chemotherapy cycle |
|
| Assessment of patient knowledge on chemotherapy side effects and support medications | Other | Questionnaire completed during patient hospitalization for the first, second and sixth cycle of chemotherapy |
|
| Assessment of patient satisfaction on pharmaceutical follow-up | Other | Questionnaire completed during patient hospitalization for the sixth chemotherapy cycle |
|